Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES
暂无分享,去创建一个
Johannes Bernarding | Claus Tempelmann | Jürgen Braun | Martin Kanowski | Jörn Kaufmann | J. Bernarding | C. Tempelmann | J. Kaufmann | M. Kanowski | J. Braun
[1] G Helms,et al. Analysis of 1.5 Tesla proton MR spectra of human brain using LCModel and an imported basis set. , 1999, Magnetic resonance imaging.
[2] J M Wardlaw,et al. Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios , 2000, Magnetic resonance in medicine.
[3] C Gössl,et al. Improved analysis of 1H‐MR spectra in the presence of mobile lipids , 2001, Magnetic resonance in medicine.
[4] K. Behar,et al. Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.
[5] J Higinbotham,et al. Use of voigt lineshape for quantification of in vivo 1H spectra , 1997, Magnetic resonance in medicine.
[6] R Gruetter,et al. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. , 1999, Journal of magnetic resonance.
[7] D P Auer,et al. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.
[8] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[9] D J Drost,et al. Factors affecting the quantification of short echo in‐vivo 1H MR spectra: prior knowledge, peak elimination, and filtering , 1999, NMR in biomedicine.
[10] C Boesch,et al. Characterization of the macromolecule baseline in localized 1H‐MR spectra of human brain , 2001, Magnetic resonance in medicine.
[11] C Boesch,et al. Versatile frequency domain fitting using time domain models and prior knowledge , 1998, Magnetic resonance in medicine.
[12] D. van Ormondt,et al. Frequency-selective quantification in the time domain , 1992 .
[13] Wolfgang Grodd,et al. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.
[14] J. Slotboom,et al. Quantitative 1H‐magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model‐fitting , 2002, Magnetic resonance in medicine.
[15] B J Soher,et al. Representation of strong baseline contributions in 1H MR spectra , 2001, Magnetic resonance in medicine.
[16] P. Williamson,et al. The use of a priori knowledge to quantify short echo in vivo 1h mr spectra , 1995, Magnetic resonance in medicine.
[17] D. Saunders,et al. Discrimination of Metabolite from Lipid and Macromolecule Resonances in Cerebral Infarction in Humans Using Short Echo Proton Spectroscopy , 1997, Journal of magnetic resonance imaging : JMRI.
[18] V. Govindaraju,et al. Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.
[19] U. Klose. In vivo proton spectroscopy in presence of eddy currents , 1990, Magnetic resonance in medicine.
[20] U. Klose,et al. Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.
[21] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[22] L Vanhamme,et al. New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES , 1998, NMR in biomedicine.